Voyager Therapeutics (VYGR) Equity Ratio: 2015-2025
Historic Equity Ratio for Voyager Therapeutics (VYGR) over the last 10 years, with Sep 2025 value amounting to 0.76.
- Voyager Therapeutics' Equity Ratio fell 1.66% to 0.76 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.76, marking a year-over-year decrease of 1.66%. This contributed to the annual value of 0.76 for FY2024, which is 13.37% up from last year.
- Latest data reveals that Voyager Therapeutics reported Equity Ratio of 0.76 as of Q3 2025, which was up 0.67% from 0.76 recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Equity Ratio registered a high of 0.78 during Q3 2024, and its lowest value of 0.32 during Q2 2022.
- In the last 3 years, Voyager Therapeutics' Equity Ratio had a median value of 0.76 in 2025 and averaged 0.72.
- Its Equity Ratio has fluctuated over the past 5 years, first soared by 131.77% in 2021, then crashed by 40.89% in 2022.
- Quarterly analysis of 5 years shows Voyager Therapeutics' Equity Ratio stood at 0.49 in 2021, then fell by 24.47% to 0.37 in 2022, then soared by 81.64% to 0.67 in 2023, then rose by 13.37% to 0.76 in 2024, then dropped by 1.66% to 0.76 in 2025.
- Its Equity Ratio was 0.76 in Q3 2025, compared to 0.76 in Q2 2025 and 0.77 in Q1 2025.